These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3556115)

  • 1. Expression of HLA antigens in paraffin sections of uveal melanomas.
    Jager MJ; de Wolff-Rouendaal D; Breebaart AC; Ruiter DJ
    Doc Ophthalmol; 1986 Dec; 64(1):69-76. PubMed ID: 3556115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.
    Krishnakumar S; Abhyankar D; Sundaram AL; Pushparaj V; Shanmugam MP; Biswas J
    Clin Cancer Res; 2003 Sep; 9(11):4159-64. PubMed ID: 14519640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of HLA class II antigens on human uveal melanoma cells after in vivo X-ray irradiation.
    Jager MJ; van der Pol JP; de Wolff-Rouendaal D; de Jong PT; Ruiter DJ
    Am J Ophthalmol; 1988 Jan; 105(1):78-86. PubMed ID: 3276205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of classic and nonclassic HLA class I antigens in uveal melanoma.
    Anastassiou G; Rebmann V; Wagner S; Bornfeld N; Grosse-Wilde H
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2016-9. PubMed ID: 12714638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA expression and tumor-infiltrating immune cells in uveal melanoma.
    de Waard-Siebinga I; Hilders CG; Hansen BE; van Delft JL; Jager MJ
    Graefes Arch Clin Exp Ophthalmol; 1996 Jan; 234(1):34-42. PubMed ID: 8750848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible relation between HLA and ABO type and prognosis of uveal melanoma.
    Jager MJ; Völker-Dieben HJ; de Wolff-Rouendaal D; Kakebeeke-Kemme H; D'Amaro J
    Doc Ophthalmol; 1992; 82(1-2):43-7. PubMed ID: 1305026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
    Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA expression in uveal melanoma: there is no rule without some exception.
    Jager MJ; Hurks HM; Levitskaya J; Kiessling R
    Hum Immunol; 2002 Jun; 63(6):444-51. PubMed ID: 12039519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigen expression on uveal melanoma cells in vivo and in vitro.
    de Waard-Siebinga I; Kool J; Jager MJ
    Hum Immunol; 1995 Oct; 44(2):111-7. PubMed ID: 8847229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uveal melanoma: no expression of HLA-G.
    Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HLA class I and class II antigen expression and mortality in uveal melanoma.
    Ericsson C; Seregard S; Bartolazzi A; Levitskaya E; Ferrone S; Kiessling R; Larsson O
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2153-6. PubMed ID: 11527924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
    Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HLA class I antigen expression correlates with histological cell type in uveal melanoma].
    Dithmar S; Crowder J; Jager MJ; Vigniswaran N; Grossniklaus HE
    Ophthalmologe; 2002 Aug; 99(8):625-8. PubMed ID: 12227276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
    Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.
    Blom DJ; Schurmans LR; De Waard-Siebinga I; De Wolff-Rouendaal D; Keunen JE; Jager MJ
    Br J Ophthalmol; 1997 Nov; 81(11):989-93. PubMed ID: 9505825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
    Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
    Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
    Carrel S; Schreyer M; Gross N; Zografos L
    Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines.
    Hurks HM; Metzelaar-Blok JA; Mulder A; Claas FH; Jager MJ
    Int J Cancer; 2000 Mar; 85(5):697-702. PubMed ID: 10699951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.
    Ma D; Niederkorn JY
    Immunology; 1995 Oct; 86(2):263-9. PubMed ID: 7490128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.